Impact of deprescribing rounds on discharge prescriptions: an interventional trial

  title={Impact of deprescribing rounds on discharge prescriptions: an interventional trial},
  author={Rachel Edey and N T Edwards and Jonah Von Sychowski and Ajay Bains and Jim Spence and Dan Martinusen},
  journal={International Journal of Clinical Pharmacy},
Background Successful deprescribing practices are required to address issues associated with polypharmacy but are hindered by minimal interprofessional collaboration, time constraints, concern for negative outcomes, and absence of a systematic and evidence-based approach. Objective Determine the impact of pharmacist-led deprescribing rounds within a clinical teaching unit (CTU) the number of home medications discontinued upon hospital discharge. Setting Canadian tertiary care hospital. Methods… Expand
Deprescribing in geriatric inpatients is associated with a lower readmission risk: a case control study
Deprescribing in geriatric inpatients was associated with a reduced readmission risk at three months post-discharge, based on the lowest Akaike information criterion. Expand
Managing Polypharmacy in Older Adults with Cancer Across Different Healthcare Settings
This paper presents a narrative, rather than a systematic review, of studies published in the past decade that provided detailed information on medication management and polypharmacy across cancer care settings, and aims to summarize different healthcare provider roles in taking action against inappropriate medication use and polyPharmacy in older adults with cancer. Expand
Practice-enhancing publications about the medication-use process in 2019.
It is important to routinely review the published literature and to incorporate significant findings into daily practice; this article assists in identifying and summarizing the most impactful recently published literature in this area. Expand
Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases
Prospective interventions to decrease polypharmacy may impact dyspnea symptoms, especially for statins, as well as in stratified models. Expand
Complex chronic patients as an emergent group with high risk of intracerebral haemorrhage: an observational cohort study
In the CCP subgroup the incidence density of ICH was 5–60 times higher than that observed in elder and general population, and the use of bleeding risk score as the HAS-BLED scale could improve the preventive approach of those with higher risk of I CH. Expand
Medication review interventions to reduce hospital readmissions in older people
To assess the efficacy of medication review as an isolated intervention and with several co‐interventions for preventing hospital readmissions in older adults, a large number of patients with a history of hospital readmission are surveyed. Expand


Deprescribing to Reduce Medication Use: Will This Help Your Patient?
  • R. Howland
  • Medicine
  • Journal of psychosocial nursing and mental health services
  • 2016
Evidence of the effectiveness of deprescribing medication on improving clinical outcomes is conflicting or lacking, and medication necessity or appropriateness should be assessed on a case-by-case basis and from visit to subsequent visit over time. Expand
The Impact of a Structured Pharmacist Intervention on the Appropriateness of Prescribing in Older Hospitalized Patients
It is indicated that DRPs are prevalent in older Irish hospital inpat patients and that a specially developed SPRM intervention supported by a CDSS can improve both the appropriateness and accuracy of medication regimens of older hospitalized inpatients. Expand
Benefits of deprescribing on patients’ adherence to medications
Deprescribing may improve adherence via reducing polypharmacy, reducing the financial costs associated with medication taking, increasing the patient’s medication knowledge through education, increasing patient engagement in medication management and resolution of adverse drug reactions. Expand
What Are Priorities for Deprescribing for Elderly Patients? Capturing the Voice of Practitioners: A Modified Delphi Process
The results suggest that deprescribing and overtreatment occurs through the full spectrum of primary care, and that evidence-based depresCribing guidelines are a priority in the care of the elderly. Expand
Review of deprescribing processes and development of an evidence‐based, patient‐centred deprescribing process
This is the first deprescribing process developed using knowledge of the patients' views of medication cessation, which focuses on engaging patients throughout the process, with the aim of improving long‐term health outcomes. Expand
Deprescribing: A narrative review of the evidence and practical recommendations for recognizing opportunities and taking action.
The aim of this narrative review is to provide an overview of "deprescribing"; firstly discussing the potential benefits and harms followed by the barriers to and enablers of deprescribes, and practical recommendations to recognise opportunities and strategies for depresCribing in practice. Expand
Reducing inappropriate polypharmacy: the process of deprescribing.
A deprescribing protocol is proposed comprising 5 steps: ascertain all drugs the patient is currently taking and the reasons for each one, and prioritize drugs for discontinuation that have the lowest benefit-harm ratio and lowest likelihood of adverse withdrawal reactions or disease rebound syndromes. Expand
Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes.
To reduce the likelihood of clinically significant adverse events, clinicians should undertake a step-wise approach to discontinuing medications and do so under appropriate supervision. Expand
The feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.
Although nonrandomized data suggested that deprescribing reduces mortality, depres cribing was not shown to alter mortality in randomized studies, and Mortality was significantly reduced when applying patient-specific interventions to depresCribe in randomized Studies. Expand
The benefits and harms of deprescribing
Cessation of use has not been studied for many medication classes, and large‐scale randomised controlled trials of systematic deprescribing are required before the true benefits and harms can be known. Expand